PFM Health Sciences’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-360,830	Closed	-$5.54M	–	75
2023 Q3	$5.54M	Buy	360,830 +67,690	+23%	+$1.04M	0.26%	60
2023 Q2	$6.97M	Buy	+293,140	New	+$6.97M	0.27%	63